News | Neuro Imaging | June 26, 2018

Smoking and Diabetes Linked to Brain Calcifications

Multiplanar brain CT allows greater distinction between hippocampal calcifications and calcifications in nearby brain structures to better assess cognitive impairment

Smoking and Diabetes Linked to Brain Calcifications

June 26, 2018 — People who smoke or have diabetes may be at increased risk of calcifications in a region of the brain crucial to memory, according to a new study published online in the journal Radiology.

Researchers have hypothesized that abnormal buildups of calcium, or calcifications, in the hippocampus may be related to vascular problems that could contribute to hippocampal atrophy and subsequent cognitive deterioration. However, published research on the association between hippocampal calcification and cognitive impairment is limited.

“We know that calcifications in the hippocampus are common, especially with increasing age,” said the study’s lead author, Esther J.M. de Brouwer, M.D., a geriatrician at the University Medical Center in Utrecht, the Netherlands. “However, we did not know if calcifications in the hippocampus related to cognitive function.”

Advances in neuroimaging have provided opportunities to explore the role of hippocampal calcifications in dementia. The development of multiplanar brain computed tomography (CT) scans has enabled better distinction between hippocampal calcifications and calcifications in nearby brain structures like the choroid plexus.

“A multiplanar CT scan makes it possible to see the hippocampus in different anatomical planes; for example, from top to bottom, right to left, and front to back,” de Brouwer said. “Before multiplanar CT scans, hippocampal calcifications were often mistaken for choroid plexus calcifications. So with multiplanar CT scans, hippocampal calcifications are better distinguished from calcifications in other areas.”  

de Brouwer and colleagues studied the association between vascular risk factors like high blood pressure, diabetes and smoking, and hippocampal calcifications. They also assessed the effects of calcifications on cognitive function.

The study group included 1,991 patients, average age 78 years, who had visited a memory clinic at a Dutch hospital between 2009 and 2015. The patients had a standard diagnostic workup including cognitive tests and brain CT scans. The researchers analyzed the CT scans for the presence and severity of hippocampal calcifications.

Of the 1,991 patients, 380 (19.1 percent) had hippocampal calcifications. Older age, diabetes and smoking were associated with an increased risk of hippocampal calcifications on CT scans.

While the study was not designed to conclusively determine if smoking and diabetes increase the risk of hippocampal calcifications, the results strongly suggest a link.

“We do think that smoking and diabetes are risk factors,” de Brouwer said. “In a recent histopathology study, hippocampal calcifications were found to be a manifestation of vascular disease. It is well known that smoking and diabetes are risk factors for cardiovascular disease. It is, therefore, likely that smoking and diabetes are risk factors for hippocampal calcifications.”

There was no link between the presence and severity of hippocampal calcifications and cognitive function — a surprising finding, according to de Brouwer, with several possible explanations.

“The hippocampus is made up of different layers, and it is possible that the calcifications did not damage the hippocampal structure that is important for memory storage,” she said. “Another explanation could be the selection of our study participants, who all came from a memory clinic.”

The researchers plan to carry out additional studies in different groups of people to better understand possible links between these calcifications and cognitive problems.

For more information: www.pubs.rsna.org/journal/radiology

Reference

de Brouwer E.J.M., Kockelkoren R., Claus J.J., et al. "Hippocampal Calcifications: Risk Factors and Association with Cognitive Function.” Radiology, June 12, 2018. https://doi.org/10.1148/radiol.2018172588

Related Content

MRI Exablate neuro helmet from INSIGHTEC

MRI Exablate neuro helmet from INSIGHTEC. Image courtesy of Ali Rezai, M.D., and RSNA.

News | Clinical Trials | December 03, 2019
December 3, 2019 — Focused ultrasound is a safe and effective way to target and open areas of the blood-brain barrier
Image by Kira Hoffmann from Pixabay  #RSNA19

Image by Kira Hoffmann from Pixabay 

News | Clinical Trials | November 30, 2019
November 30, 2019 — Researchers are trying to identify injury patterns and predict future outcomes for victims of gun
This bar graph shows breast cancer presentation by screening interval #RSNA19

This bar graph shows breast cancer presentation by screening interval. Image courtesy of study author and RSNA

News | Breast Imaging | November 28, 2019
November 28, 2019 — Cancers found in patients undergoing annual...
Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Photo courtesy of Thorsten Mohr/Saarland University

News | Prostate Cancer | November 28, 2019
November 28, 2019 — Reports of new cancer treatments
Reduction in fractional anisotropy (FA) in obese patients compared to the control group

Reduction in fractional anisotropy (FA) in obese patients compared to the control group: At the intersection of the alignment vectors, a large cluster of FA decrease located in the corpus callosum on the left. In red: Reduction of FA in obese patients compared to controls, and FA skeleton (green), superimposed on the mean of FA images in sample. Image courtesy of Pamela Bertolazzi, Ph.D., and RSNA.

News | Clinical Trials | November 25, 2019
November 25, 2019 — Researchers using magn...
With the HiRise, musculoskeletal radiologists and orthopedic specialists will be able to assess alignment of the total leg in three dimensions
News | Computed Tomography (CT) | November 25, 2019
November 25, 2019 — CurveBeam introduced the next level of weight-bearing...
One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice
News | Clinical Trials | November 21, 2019
November 21, 2019 — One in three adults treated for cancer may experience side effects from treatment they wish they
The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source computed tomography (CT) scanner from Siemens Healthineers together with the new myExam Companion intelligent user interface concept
News | Computed Tomography (CT) | November 21, 2019
November 21, 2019 — The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source